Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 44: 724-730, 1998;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (28)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poropat, R. A.
Right arrow Articles by Nicholson, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poropat, R. A.
Right arrow Articles by Nicholson, G. A.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 1998;44:724-730.)
© 1998 American Association for Clinical Chemistry, Inc.

Molecular Pathology and Genetics

Determination of gene dosage at the PMP22 and androgen receptor loci by quantitative PCR

Renee A. Poropata, and Garth A. Nicholson

a Address correspondence to this author at: Molecular Medicine Laboratory, University of Sydney, Clinical Sciences Building, Concord Hospital, Concord, New South Wales 2139, Australia. Fax 61-2-9767 6194; e-mail rporopat{at}med.usyd.edu.au.

Although many genetic diseases are caused by the presence of point mutations in respective genes, an increasing number of diseases are known to be caused by gene copy number changes. We report the development of a rapid and reliable PCR-based method for quantitation of gene copy number with sufficient sensitivity to detect single copy changes without the use of radioactive or fluorescent labeling. The sensitivity of this technique has been demonstrated by the detection of the DNA duplication or deletion occurring in two inherited peripheral neuropathies, Charcot-Marie-Tooth type 1A (CMT1A) and hereditary neuropathy with liability to pressure palsies (HNPP), that are caused by a reciprocal duplication or deletion event on chromosome 17p11.2–12. This method relies on the comparison of the amount of PCR product generated from a potentially duplicated or deleted target sequence with the amount of product generated from a disomic reference gene. The value of this ratio (target PCR product:reference PCR product) indicates whether the target sequence is duplicated, deleted, or unchanged. Using primers from within a duplicated or deleted region (PMP22 gene and EW401) and from within a reference region (NF1 gene), we tested 50 CMT1A, 30 HNPP, and 50 unaffected individuals for the presence of a DNA duplication or deletion. Target:reference ratios of 1.58, 1.02, and 0.56 were detected for the CMT1A, unaffected, and HNPP groups, respectively. Thus, differentiation of the three groups of individuals was on the basis of gene copy number. This technique was successfully used to detect the difference in the X chromosome copy number between males and females (target:reference ratios of 1.1 and 2.3, respectively). This approach to the detection of DNA duplications and deletions is sensitive, accurate, and has potential applications in the quantitation of changes in gene copy number associated with diseases characterized by such chromosomal alterations.




The following articles in journals at HighWire Press have cited this article:


Home page
 Mol Hum ReprodHome page
A.M. Ottesen, I.D. Garn, L. Aksglaede, A. Juul, and E. Rajpert-De Meyts
A simple screening method for detection of Klinefelter syndrome and other X-chromosome aneuploidies based on copy number of the androgen receptor gene
Mol. Hum. Reprod., October 1, 2007; 13(10): 745 - 750.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. O. Indsto, N. T. Nassif, R. F. Kefford, and G. J. Mann
Frequent Loss of Heterozygosity Targeting the Inactive X Chromosome in Melanoma
Clin. Cancer Res., December 15, 2003; 9(17): 6476 - 6482.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. L. Badano, K. Inoue, N. Katsanis, and J. R. Lupski
New Polymorphic Short Tandem Repeats for PCR-based Charcot-Marie-Tooth Disease Type 1A Duplication Diagnosis
Clin. Chem., May 1, 2001; 47(5): 838 - 843.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
C. Ruiz-Ponte, L. Loidi, A. Vega, A. Carracedo, and F. Barros
Rapid Real-Time Fluorescent PCR Gene Dosage Test for the Diagnosis of DNA Duplications and Deletions
Clin. Chem., October 1, 2000; 46(10): 1574 - 1582.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
T. W. Prior
Determining Gene Dosage
Clin. Chem., April 1, 1998; 44(4): 703 - 704.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Association for Clinical Chemistry.